Drug Trial Radar · NCT00043927
Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults
Last checked: Nov 19, 2026Latest source record: Aug 21, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
760
Actual
Start
Apr 2001
Primary completion
Jan 2004
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Aug 16, 2002
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will gather and compare data about the effectiveness and safety of two different treatments for extensive Small Cell Lung Cancer (SCLC) in patients who have not received previous chemotherapy. One treatment will use an investigational drug in combination with an FDA approved chemotherapy. The other treatment will use a combination of two FDA approved chemotherapy drugs.
Conditions
- Small Cell Lung Cancer
Interventions
topotecan/cisplatinDrug
etoposide/cisplatinDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival
Locations
176 sites in 34 countries. Site status is shown where the registry gives one.
GSK Clinical Trials Call Center
Hoover, Alabama
GSK Clinical Trials Call Center
Chula Vista, California
GSK Clinical Trials Call Center
Fountain Valley, California
GSK Clinical Trials Call Center
Greenbrae, California
GSK Clinical Trials Call Center
Poway, California
GSK Clinical Trials Call Center
Rancho Mirage, California
GSK Clinical Trials Call Center
Sacramento, California
GSK Clinical Trials Call Center
San Diego, California
GSK Clinical Trials Call Center
San Diego, California
GSK Clinical Trials Call Center
Soquel, California
GSK Clinical Trials Call Center
Vista, California
GSK Clinical Trials Call Center
Colorado Springs, Colorado
GSK Clinical Trials Call Center
Norwich, Connecticut
GSK Clinical Trials Call Center
Washington D.C., District of Columbia
GSK Clinical Trials Call Center
Gainesville, Florida
GSK Clinical Trials Call Center
Miami Shores, Florida
GSK Clinical Trials Call Center
Ocala, Florida
GSK Clinical Trials Call Center
Pensacola, Florida
GSK Clinical Trials Call Center
Tarpon Springs, Florida
GSK Clinical Trials Call Center
Atlanta, Georgia
GSK Clinical Trials Call Center
Atlanta, Georgia
GSK Clinical Trials Call Center
Atlanta, Georgia
GSK Clinical Trials Call Center
Atlanta, Georgia
GSK Clinical Trials Call Center
Augusta, Georgia
GSK Clinical Trials Call Center
Cumming, Georgia
GSK Clinical Trials Call Center
Decatur, Georgia
GSK Clinical Trials Call Center
Aurora, Illinois
GSK Clinical Trials Call Center
Chicago, Illinois
GSK Clinical Trials Call Center
Chicago, Illinois
GSK Clinical Trials Call Center
Elk Grove Village, Illinois
GSK Clinical Trials Call Center
Park Ridge, Illinois
GSK Clinical Trials Call Center
Evansville, Indiana
GSK Clinical Trials Call Center
South Bend, Indiana
GSK Clinical Trials Call Center
New Orleans, Louisiana
GSK Clinical Trials Call Center
Shreveport, Louisiana
GSK Clinical Trials Call Center
Frederick, Maryland
GSK Clinical Trials Call Center
Pittsfield, Massachusetts
GSK Clinical Trials Call Center
Minneapolis, Minnesota
GSK Clinical Trials Call Center
St Louis, Missouri
GSK Clinical Trials Call Center
Reno, Nevada
Showing 40 of 176 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.